Inhibition of CDK4/6 as Therapeutic Approach for Ovarian Cancer Patients: Current Evidences and Future Perspectives

SIMPLE SUMMARY: Altered regulation of the cell cycle is a hallmark of cancer. The recent clinical success of the inhibitors of CDK4 and CDK6 has convincingly demonstrated that targeting cell cycle components may represent an effective anti-cancer strategy, at least in some cancer types. However, pos...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: Dall’Acqua, Alessandra, Bartoletti, Michele, Masoudi-Khoram, Nastaran, Sorio, Roberto, Puglisi, Fabio, Belletti, Barbara, Baldassarre, Gustavo
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8235237/
https://ncbi.nlm.nih.gov/pubmed/34204543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13123035
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky